Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

39.31
Delayed Data
As of Jun 30
 +0.74 / +1.92%
Today’s Change
36.00
Today|||52-Week Range
51.74
-12.47%
Year-to-Date
Traders, Here's Your 'Short' Notice
Jun 30 / TheStreet.com - Paid Partner Content
Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun 20 / Zacks.com - Paid Partner Content
Mylan Launches Generic Version of Glaxo's Avodart in U.S.
Jun 27 / Zacks.com - Paid Partner Content
Abbott Laboratories (ABT) Is in Oversold Territory: What's Next?
Jun 17 / Zacks.com - Paid Partner Content
Medtronic Acquires HeartWare With Some Activist Inspiration
Jun 27 / TheStreet.com - Paid Partner Content
Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Jun 17 / Zacks.com - Paid Partner Content
Becton Dickinson: 19% EPS Growth With Good Dividends
Jun 26 / GuruFocus News - Paid Partner Content